Client News

SANTA CLARA, Calif. and LONDON, UK –– 27 February, 2012 —Cambridge Broadband Networks Limited, a manufacturer of point-to-multipoint packet microwave backhaul solutions for mobile broadband network operators, today announced that it has secured a $7.0 million line of credit from Silicon Valley Bank,...

Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, today secured $15 million in venture debt financing from Silicon Valley Bank and Oxford Finance.

LockerDome, a social sports community, announced today that it has been selected as the only St. Louis-based company to present at the prestigious Silicon Valley Bank Showcase event on March 22, in Silicon Valley.  

NXT Capital’s Venture Finance Group today announced the closing of a $7 million venture loan package with Estech, Inc. Made in cooperation with Silicon Valley Bank, the facility will enable Estech to finance key growth initiatives.

AssureRx Health, Inc., today announced that it has secured an $8 million Term and Revolving Credit Facility that provides additional capital to support increasing clinical adoption of GeneSightRx and to finance multiple new products scheduled for launch in 2012.

SnagFilms announced today that it has closed a new, seven-figure financing round to accelerate the growth the company achieved in 2011.

has obtained aSenior Credit Facility to acquire January 2012 Provided by:   Administrative Agent  About Silicon Valley BankSilicon Valley Bank is the premier commercial bank for companies in the technology, life science, cleantech, venture capital, private equity and premium wine industries. SVB ...

Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced a $15 million round of debt financing for Vitae Pharmaceuticals (“Vitae”).

Online pricing intelligence firm Channel IQ announced late Tuesday it secured a line of credit from Silicon Valley Bank, part of Santa Clara, Calif.-based SVB Financial Group.